
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : NAC-GED-0507
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Torii Pharmaceutical
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Under the agreement, Torii Pharmaceuticals will gain exclusive development and commercialisation rights for NAC-GED-0507 in Japan for the treatment of acne vulgaris. NAC-GED-0507 is an IP protected, Phase III-ready, small molecule selective modulator of ...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 26, 2023
Lead Product(s) : NAC-GED-0507
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Torii Pharmaceutical
Deal Size : Undisclosed
Deal Type : Licensing Agreement
